Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.390
-0.150 (-3.30%)
Jun 13, 2025, 2:40 PM - Market open
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Foghorn Therapeutics stock ranges from a low of $9.00 to a high of $20. The average analyst price target of $12.63 forecasts a 187.70% increase in the stock price over the next year.
Price Target: $12.63 (+187.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +105.01% | May 15, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +105.01% | Apr 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +196.13% | Apr 30, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $9 | Buy | Initiates | $9 | +105.01% | Apr 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +196.13% | Mar 7, 2025 |
Financial Forecast
Revenue This Year
29.77M
from 22.60M
Increased by 31.70%
Revenue Next Year
31.97M
from 29.77M
Increased by 7.40%
EPS This Year
-1.41
from -1.58
EPS Next Year
-1.40
from -1.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 37.8M | 52.5M | 52.5M | ||
| Avg | 29.8M | 32.0M | 41.5M | ||
| Low | 19.6M | n/a | 19.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.2% | 76.4% | 64.2% | ||
| Avg | 31.7% | 7.4% | 29.9% | ||
| Low | -13.3% | - | -38.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.03 | -0.83 | -0.90 | ||
| Avg | -1.41 | -1.40 | -1.51 | ||
| Low | -1.68 | -1.73 | -2.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.